CHRONIC HEPATITIS D INFECTION
Clinical trials for CHRONIC HEPATITIS D INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS D INFECTION trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS D INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare liver disease: experimental drug shows promise
Disease control OngoingThis study tests a new medicine called BJT-778 for people with chronic hepatitis delta, a serious liver infection. About 150 adults will either start the drug right away or wait 24 weeks before starting it. The goal is to see if the drug can lower virus levels and improve liver h…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE2, PHASE3 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 09:25 UTC
-
New drug bulevirtide tracked in real-world hepatitis d patients
Disease control OngoingThis study follows 170 people with chronic hepatitis D who are taking bulevirtide to see how the drug affects their liver health over time. Researchers will monitor for serious liver problems like liver failure, cancer, or need for transplant, as well as side effects. The goal is…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 26, 2026 08:33 UTC